NCT07094204 2026-04-15
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Astellas Pharma Inc
Phase 1 Recruiting
Clinical Trials
6 trialsNCT07021898 2025-12-03
BOREALIS-1
Erasca, Inc.
Phase 1 Recruiting
NCT06983743 2025-09-11
AURORAS-1
Erasca, Inc.
Phase 1 Recruiting
NCT00563316 2016-04-12
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
Amgen
Phase 1 Completed
NCT00879385 2014-10-31
KRAS Wild-type Metastatic Colorectal Cancer Trial
University of Utah
Phase 1 Completed
NCT00091806 2009-07-10
Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors
Amgen
Phase 1 Completed